Proteomics, genomics topics for November ACS ProSpectives' conference

September 24, 2003

The American Chemical Society, the world's largest scientific society, will hold this year's last ACS ProSpectives conference on Nov. 9-12 at the Lansdowne Conference Center, Leesburg, Va., on "Rendering Biological Knowledge from Proteomics and Genomics." The 2004 conference schedule will be announced soon.

Volumes of data are generated from proteomics and genomics technologies. Are scientists burying themselves in details or are they simply gathering information that will help them better understand how biological systems can be modulated (new targets) and monitored (biomarkers)? These questions will be addressed at the conference.

Among the specific topics to be covered are: experimental data generated from multiple technologies, intercellular dynamic biology, intercellular or organism behavior, simulation and models, data production from technology, data analysis and interference and disease characterized by proteomics.

Ruth Van Bogelen of Pfizer and Eric Neumann of Beyond Genomics are chairs for the meeting.

ACS ProSpectives is a series of small conferences for senior-level industry scientists. Each conference examines a field's important topics through presentations by its foremost researchers.

Space is limited for these meetings. Attendance at the conferences is limited to 200 or fewer to facilitate easy interaction among the speakers and those attending. From 20-25 leading experts in each field participate in a given conference. The conferences are in addition to the Society's two national meetings and its eight to ten regional meetings held every year.

Further details about the conferences, including instructions on how to register and arrange lodging, are available on This site is updated regularly with the latest information about upcoming ACS ProSpectives conferences.

# # #

(EDITOR'S NOTE -- News media wishing to attend the conferences should contact Michael Bernstein at 202-872-6042 or at

American Chemical Society

Related Proteomics Articles from Brightsurf:

Recipe for success -- interaction proteomics become a household item
A research team from University of Helsinki introduces a new optimised and integrated interaction proteomics protocol that combines two state-of-the art methods to allow rapid identification of protein-protein interactions and more.

New technology CF LINK for protein bioconjugation and structural proteomics
CF Plus Chemicals, a spin-off of ETH Zurich, IOCB Prague, and IMIC have developed a new technology called CF LINK for site-selective bioconjugation of proteins and also their structural characterization.

New proteomics technique gives insights into ubiquitin signalling
Australian researchers are among the first in the world to have access to a new approach to understand intricate changes that control how proteins function in our cells in health and disease.

Computational advances in the label-free quantification of cancer proteomics data
In this paper, the recent advances and development in the computational perspective of LFQ in cancer proteomics were systematically reviewed and analyzed.

Proteomics studies on the basic biology of Alzheimer's, cancer and listeriosis
Recent articles in the journal Molecular & Cellular Proteomics investigate metabolic quirks of cancer cells, the effects of inhibiting the enzyme that generates amyloid beta, and the mechanism by which a bacterial toxin kills host cells.

Finnish scientists analyzed the proteome of T helper 17 cells
T helper 17 (Th17) cells belong to a group of T cells with essential functions in autoimmune diseases and inflammation.

Researchers can count on improved proteomics method
Princeton's Martin Wühr has improved upon his method to accurately count the proteins present in a cell under different circumstances.

Painless real-time proteomics may one day speed up cancer surgery
Researchers at the University of Lille developed a matrix-assisted ion source for mass spectrometry that can liberate lipids and metabolites from the skin without causing pain.

Using proteomics to understand pathogens
Recent studies in the journal Molecular & Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus.

Novel proteomics strategies aid cancer research
This month's issue of the journal Molecular & Cellular Proteomics features several studies using novel proteomics methods to address unanswered questions in cancer research, including protein variation within tumors; the failure of some candidate cancer drugs; and how chemotherapeutic combinations act synergistically.

Read More: Proteomics News and Proteomics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to